Thursday, January 23, 2025

Healthcare

3 SmallCap Stocks to Watch $OSTX $WCU $LVO

Always neat to introduce timely juniors with great potential. In this case, our constituents are OS Therapies (NYSE American: OSTX) ("OS Therapies" or "the Company"),...

OS Therapies Advances in Osteosarcoma Treatment

Successfully raised $6.4 million in IPO, securing operations through mid-2025. Prioritizing fast-tracked development of OST-HER2, a promising treatment for HER-2 positive osteosarcoma. Positioned to capitalize on...

Safe Supply Streaming Co Ltd. Partners with Greenlane to Revolutionize Drug Detection and Wellness Testing (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) 

Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or "the Company") is a publicly-traded company that specializes in the acquisition, investment,...

OS Therapies Pioneers Hope for Osteosarcoma Patients 

OS Therapies is advancing therapies focused on HER-2 positive osteosarcoma, addressing a critical unmet need. The company draws inspiration from "Osteo-Angels," individuals whose battles against...

OSTX’s OST-HER2: A Potential Game-Changer for Osteosarcoma (NYSE-A: OSTX)

ROCKVILLE, Md. & NEW YORK, August 02, 2024--(BUSINESS WIRE)--OS Therapies Incorporated ("OS Therapies" or the "Company") (NYSE-A: OSTX), a Cancer Immunotherapy and Antibody Drug Conjugate...

Popular

Subscribe